All Phenotypes Tg(Krt1-5-cre/ERT)1Ipc MGI Mouse

Phenotypes associated with this allele

Jump to	Allelic Composition	Genetic Background	Genotype ID
cn1	Plec^tm2Gwi/Plec^tm4Gwi Tg(Krt1-5-cre/ERT)1Ipc/?	involves: 129 * C57BL/6 * SJL	MGI:3723353
cn2	Jun^tm4Wag/Jun^tm4Wag Junb^tm3Wag/Junb^tm3Wag Tg(Krt1-5-cre/ERT)1Ipc/0	involves: 129P2/OlaHsd * C57BL/6 * SJL	MGI:5578332
cn3	Chuk^tm1Yhu/Chuk^tm1Yhu Tg(Krt1-5-cre/ERT)1Ipc/0	involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL	MGI:3817627
cn4	Gt(ROSA)26Sor^{tm1(Smo/EYFP)Amc}/Gt(ROSA)26Sor^{tm1(Smo/EYFP)Amc} Tg(Krt1-5-cre/ERT)1Ipc/0	involves: 129X1/SvJ * C57BL/6 * SJL	MGI:4452397

Allelic Composition	Plec^tm2Gwi/Plec^tm4Gwi Tg(Krt1-5-cre/ERT)1Ipc/?
Genetic Background	involves: 129 * C57BL/6 * SJL

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Plec^tm2Gwi mutation (0 available); any Plec mutation (174 available)
Plec^tm4Gwi mutation (0 available); any Plec mutation (174 available)
Tg(Krt1-5-cre/ERT)1Ipc mutation (0 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

homeostasis/metabolism

impaired skin barrier function ( J:124213 )

• following treatment with tamoxifen and tape stripping (10 times), mice exhibit increased transepidermal water loss not observed in control Plec1^tm4Gwi homozygotes

integument

impaired skin barrier function ( J:124213 )

• following treatment with tamoxifen and tape stripping (10 times), mice exhibit increased transepidermal water loss not observed in control Plec1^tm4Gwi homozygotes

blistering ( J:124213 )

• following treatment with tamoxifen and tape stripping (10 times), mice develop small blisters

abnormal skin condition ( J:124213 )

• skin around lesions induced by treatment with tamoxifen and tape stripping (10 times) is more fragile

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

integument

skin inflammation ( J:116380 )

• intra-epidermal T cells, epidermal micro-abscesses and typical inflammatory-cell infiltrate consisting of neutrophils, and an increase in numbers of macrophages in the dermis are seen in mice 8-10 days after tamoxifen induction

abnormal skin morphology ( J:116380 )

• mice treated with tamoxifen show an increase in subepidermal vascularization

hyperkeratosis ( J:116380 )

• thickening of keratinized upper layers in mice treated with tamoxifen

parakeratosis ( J:116380 )

• in mice treated with tamoxifen

thick epidermis ( J:116380 )

• mice treated with tamoxifen show thickened epidermis with prominent rete ridge

psoriasis ( J:116380 )

• mice treated with tamoxifen at 8 weeks of age develop psoriasis-like skin lesions on hairless skin 8-10 days after tamoxifen induction, showing scaly plaques affecting primarily ears, paws and tail, and less frequently the hairy back skin

immune system

increased inflammatory response ( J:116380 )

• periostitis in mice treated with tamoxifen

autoimmune arthritis ( J:116380 )

• arthritic lesions similar to psoriatic arthritis are seen in 100% of mice treated with tamoxifen, showing inflammatory infiltrates in joint regions

skin inflammation ( J:116380 )

skeleton

autoimmune arthritis ( J:116380 )

• arthritic lesions similar to psoriatic arthritis are seen in 100% of mice treated with tamoxifen, showing inflammatory infiltrates in joint regions

abnormal bone structure ( J:116380 )

• massive bone destruction

abnormal periosteum morphology ( J:116380 )

• periostitis in mice treated with tamoxifen

cardiovascular system

abnormal blood vessel morphology ( J:116380 )

• mice treated with tamoxifen show an increase in subepidermal vascularization

Mouse Models of Human Disease		DO ID	OMIM ID(s)	Ref(s)
psoriasis		DOID:8893	OMIM:PS177900	J:116380

Allelic Composition	Chuk^tm1Yhu/Chuk^tm1Yhu Tg(Krt1-5-cre/ERT)1Ipc/0
Genetic Background	involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Chuk^tm1Yhu mutation (0 available); any Chuk mutation (51 available)
Tg(Krt1-5-cre/ERT)1Ipc mutation (0 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

increased skin tumor incidence ( J:141162 )

• 10 to 12 months following induction with tamoxifen

integument

epidermal hyperplasia ( J:141162 )

• after tamoxifen induction, mice exhibit dorsal epidermis hyperplasia

increased skin tumor incidence ( J:141162 )

• 10 to 12 months following induction with tamoxifen

Allelic Composition	Gt(ROSA)26Sor^{tm1(Smo/EYFP)Amc}/Gt(ROSA)26Sor^{tm1(Smo/EYFP)Amc} Tg(Krt1-5-cre/ERT)1Ipc/0
Genetic Background	involves: 129X1/SvJ * C57BL/6 * SJL

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sor^{tm1(Smo/EYFP)Amc} mutation (1 available); any Gt(ROSA)26Sor mutation (993 available)
Tg(Krt1-5-cre/ERT)1Ipc mutation (0 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

increased basal cell carcinoma incidence ( J:158915 )

• tamoxifen-treated mice develop basal cell carcinomas that are restricted to the epidermis

integument

increased basal cell carcinoma incidence ( J:158915 )

• tamoxifen-treated mice develop basal cell carcinomas that are restricted to the epidermis

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 12/10/2024 MGI 6.24